Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:30 PM
Ignite Modification Date:
2025-12-25 @ 5:11 PM
NCT ID:
NCT00723203
Group ID:
EG000
Title:
Treatment (Panobinostat)
Description:
Patients receive oral panobinostat once on days 1, 3, and 5. Treatment repeats every 28 days for up to 6 courses in the absence of disease progression or unacceptable toxicity.
panobinostat: 40 mg Monday, Wednesday and Friday of every week in a 28 day cycle
gene expression analysis: Day 1 and day 28 samples
reverse transcriptase-polymerase chain reaction: Day 1 and day 28 samples
laboratory biomarker analysis: Day 1 and day 28 samples
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
11
Serious Number At Risk:
16
Other Number Affected:
16
Other Number At Risk:
16
Study:
NCT00723203
Results Section:
NCT00723203
Adverse Events Module:
NCT00723203